Search by Drug Name or NDC
NDC 16477-0422-06 Selenium Sulfide 22.5 mg/mL Details
Selenium Sulfide 22.5 mg/mL
Selenium Sulfide is a TOPICAL SHAMPOO in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Laser Pharmaceuticals, LLC. The primary component is SELENIUM SULFIDE.
MedlinePlus Drug Summary
Selenium sulfide, an anti-infective agent, relieves itching and flaking of the scalp and removes the dry, scaly particles that are commonly referred to as dandruff or seborrhea. It is also used to treat tinea versicolor, a fungal infection of the skin. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 16477-0422-06Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Selenium Sulfide
Product Information
NDC | 16477-0422 |
---|---|
Product ID | 16477-422_e8944cc2-dca5-1210-e053-2a95a90a406f |
Associated GPIs | 90300050004525 |
GCN Sequence Number | 058399 |
GCN Sequence Number Description | selenium sulfide SHAMPOO 2.25 % TOPICAL |
HIC3 | L5E |
HIC3 Description | ANTISEBORRHEIC AGENTS |
GCN | 23824 |
HICL Sequence Number | 013406 |
HICL Sequence Number Description | SELENIUM SULFIDE |
Brand/Generic | Generic |
Proprietary Name | Selenium Sulfide |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Selenium Sulfide |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | SHAMPOO |
Route | TOPICAL |
Active Ingredient Strength | 22.5 |
Active Ingredient Units | mg/mL |
Substance Name | SELENIUM SULFIDE |
Labeler Name | Laser Pharmaceuticals, LLC |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | UNAPPROVED DRUG OTHER |
Application Number | n/a |
Listing Certified Through | 2024-12-31 |
Package
Package Images

NDC 16477-0422-06 (16477042206)
NDC Package Code | 16477-422-06 |
---|---|
Billing NDC | 16477042206 |
Package | 180 mL in 1 BOTTLE (16477-422-06) |
Marketing Start Date | 2022-04-11 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL dc6609b4-1757-3a13-e053-2995a90ac172 Details
SPL UNCLASSIFIED SECTION
DESCRIPTION: A liquid antiseborrheic, antifungal preparation for topical application. Each mL of Selenium Sulfide 2.25% Shampoo contains 22.5 mg selenium sulfide, and the following inactive ingredients: butylated hydroxytoluene, cetyl alcohol, citric acid, cocamidopropyl betaine, disodium EDTA, D&C yellow #10, FD&C red #40, fragrance, panthenol, phenoxyethanol, propylene glycol, purified water, stearyl alcohol, sodium laureth sulfate, sodium thiosulfate, tocopheryl acetate, triacetin, urea, xanthan gum.
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
WARNINGS: For external use only. Not for ophthalmic use.
DO NOT USE ON BROKEN SKIN OR INFLAMED AREAS. If allergic reaction occurs, discontinue use. Avoid contact with eyes, genital areas and skin folds, as irritation and burning may result. If accidental contact occurs, rinse thoroughly with water. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
SPL UNCLASSIFIED SECTION
PRECAUTIONS: This medication is to be used as directed by a physician. Not to be used when inflammation or exudation is present as increased absorption may occur.
CARCINOGENESIS: Dermal application of 25% and 50% solutions of 2.5% selenium sulfide lotion on mice over an 88-week period indicated no carcinogenic effects.
USE IN PREGNANCY:
CATEGORY C
Animal reproduction studies have not been conducted with this medication. It is also not known whether this product can cause fetal harm when applied to the body surfaces of a pregnant woman or can affect reproduction capacity. Under ordinary circumstances, selenium sulfide 2.25% shampoo should not be used by pregnant women.
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
OVERDOSAGE: There are no documented reports of serious toxicity in humans resulting from acute ingestion of selenium sulfide 2.25% shampoo. However, acute toxicity studies in animals suggest that ingestion of large amounts could result in potential human toxicity. Evacuation of the stomach contents should be considered in cases of acute oral ingestion.
SPL UNCLASSIFIED SECTION
DOSAGE AND ADMINISTRATION:
SHAKE WELL BEFORE USING For
seborrheic dermatitis and
dandruff: Generally 2 applications each week for 2 weeks will control symptoms. Subsequently, shampoo may be used less frequently – weekly, every 2 weeks, every 3 to 4 weeks or as directed by a physician. Should not be applied more frequently than necessary to maintain control.
For
tinea versicolor: Wet skin and apply to affected areas. Massage gently into skin working to a full lather. Allow product to remain on skin for 10 minutes, then rinse thoroughly. Repeat procedure once a day for seven days or as directed by a physician.
SPL UNCLASSIFIED SECTION
HOW SUPPLIED: Selenium Sulfide 2.25% Shampoo is supplied in 6 fluid oz. (180 mL) bottles, NDC 16477-422-06. Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (between 59°F and 86°F). Brief exposure to temperatures up to 40°C (104°F) may be tolerated provided the mean kinetic temperature does not exceed 25°C (77°F); however, such exposure should be minimized. Protect from freezing.
All prescription substitutions and / or recommendations using this product shall be made subject to state and federal statutes as applicable. Please NOTE: This is not an Orange Book product and has not been subjected to FDA therapeutic equivalency or otherequivalency testing. No representation is made as to generic status or bioequivalency. Each person recommending a prescription substitution using this product shall make such recommendations based on each such person’s professional opinion and knowledge, upon evaluating the active ingredients, inactive ingredients (excipients) and other chemical information provided herein.
SPL UNCLASSIFIED SECTION
PRINCIPAL DISPLAY PANEL
INGREDIENTS AND APPEARANCE
SELENIUM SULFIDE
selenium sulfide shampoo |
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
Labeler - Laser Pharmaceuticals, LLC (614417132) |